Nabriva Therapeutics Plc
(OTC) NBRVF
Nabriva Therapeutics Plc Financials at a Glance
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$29.39M
Net Income (TTM)
-$55.05M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-230.46 (Low)
Dividend
$0.00
Beta (Volatility)
-230.46 (Low)
Price
$0.00
Volume
480
Open
$0.00
Price
$0.00
Volume
480
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
May 29, 2026
Dividend
$0.00
Beta (Volatility)
-230.46 (Low)
Price
$0.00
Volume
480
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
May 29, 2026
NBRVF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nabriva Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
39
CEO
Theodore R. Schroeder
Website
www.nabriva.comHeadquarters
Dublin, DU 4, IE
NBRVF Financials
Key Financial Metrics (TTM)
Gross Margin
19.87%
Operating Margin
-155.57%
Net Income Margin
-160.33%
Return on Equity
-201.91%
Return on Capital
-651.75%
Return on Assets
-180.03%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
3.23M
Volume
480
Avg. Volume
80.677
Financials (TTM)
Gross Profit
-$4.89M
Operating Income
-$54.03M
EBITDA
-$53.61M
Operating Cash Flow
-$12.91M
Capital Expenditure
-$115.02K
Free Cash Flow
-$13.02M
Cash & ST Invst.
$2.18M
Total Debt
$540.00K
Nabriva Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.57M
-70.7%
Gross Profit
-$6.50M
-250.4%
Gross Margin
-2.53%
N/A
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.69
N/A
Employees
39
N/A
Net Income
-$12.06M
-8.9%
EBITDA
-$12.01M
-16.3%
Quarterly Fundamentals
Total Cash
$2.18M
-89.1%
Total Debt
$540.00K
-92.4%
Accounts Receivable
$4.44M
-64.1%
Inventory
$0.00
-100.0%
Long Term Debt
$344.00K
-32.8%
Short Term Debt
$196.00K
-97.0%
Return on Assets
-1.80%
N/A
Return on Invested Capital
-13.34%
N/A
Free Cash Flow
$511.00K
+103.9%
Operating Cash Flow
$511.00K
+103.9%